Skip to content

Clinical research on the Ganmaidazao Decoction Treating Anxiety in Parkinson's Disease based on the anti-inflammatory mechanism

Clinical research on the Ganmaidazao Decoction Treating Anxiety in Parkinson's Disease based on the anti-inflammatory mechanism

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068573
Enrollment
Unknown
Registered
2023-02-23
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety in Parkinson's disease

Interventions

Control group:On the basis of routine treatment of PD, oral Ganmai Dazao Decoction
Treated group:Oral placebo on the basis of routine treatment for PD

Sponsors

Shunde Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Patients who was diagnosed as Parkinson's disease 2: Have anxiety symptoms 3: 55~80 years old 4: Clear of mind and stable vital signs 5: Voluntarily accept the experimental study and gave informed consent

Exclusion criteria

Exclusion criteria: 1: Patients who cannot be diagnosed as Anxiety of Parkinson's disease 2: Have serious diseases, such as brain trauma, serious liver and kidney, blood, tumor, endocrine diseases 3: Participate in the clinical trials of other drugs at the same time 4: Have severe mental illness (except for patients with depression and anxiety status 5: Alcoholism or substance abuse 6: Diabetes mellitus or abnormal glucose tolerance 7: Allergy to the drugs used in this study.

Design outcomes

Primary

MeasureTime frame
HAMA score;

Secondary

MeasureTime frame
UPDRS ? score;

Countries

China

Contacts

Public ContactWu Chaoyin

Shunde Hospital of Guangzhou University of Traditional Chinese Medicine

wuchaoyin1919@163.com13226635090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026